UK regulators say people with a ‘significant medical history’ of allergic reactions should not be given the new Pfizer-BioNTech vaccine while examining two side effects that occurred on the first day of the country’s mass vaccination program
London – UK regulators on Wednesday said people with a “significant history” of allergic reactions should not receive the new Pfizer-BioNTech vaccine while investigating two side effects that occurred on the first day of the country’s mass vaccination program .
Professor Stephen Powis, National Medical Director for the National Health Service in England, said the health authorities had acted on a recommendation from the Medicines and Health Products Regulatory Agency.
“Like the new vaccines, the MHRA has advised, as a precaution, that people with a significant allergic reaction should not receive this vaccine after two people with a significant allergic reaction reacted negatively yesterday,” Powis said in a statement. . – They’re both recovering well.
The comments came when Dr. June Raine, head of the MHRA, told a parliamentary committee that regulators had had an allergic reaction to two vaccines.
“We know from very extensive clinical trials that this was not typical,” he said. “But if we need to strengthen our advice, now that we’ve gained that experience with vulnerable groups, the groups that have been selected as priorities, we get those advice right away.
Raine’s comments came as part of a general discussion about how his agency will continue to monitor people who receive a vaccine authorized for emergency use last week.
